Table 2 Estimated hepatitis C virus seroprevalence and estimated number of seropositive individuals, 2013–2014, Belgium
From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
Demographic characteristic | HCV seropositivity 2013–2014 | |||||
|---|---|---|---|---|---|---|
Number in study sample | Prevalence in Belgium | Individuals in Belgium | ||||
% | 95% CI | n | 95% CI | |||
Sex | Female | 2 | 0.13 | 0.03–0.59 | 7200 | 1510–33,520 |
Male | 4 | 0.32 | 0.1–1.03 | 17,450 | 5370–56,380 | |
Region | Brussels-Capital | 2 | 1.05 | 0.35–3.15 | 12,180 | 4020–36,320 |
Flanders | 4 | 0.21 | 0.07–0.66 | 13,300 | 4180–42,180 | |
Wallonia | 0 | 0 | 0–0.46 | 0 | 0–16,390 | |
Age group (in years) | < 20 | 1 | 0.08 | 0.01–0.54 | 1990 | 290–13,700 |
≥20 | 5 | 0.26 | 0.10–0.64 | 22,220 | 8890–55,420 | |
20–29 | 0 | 0 | 0–0.98 | 0 | 0–13,670 | |
30–39 | 1 | 0.31 | 0.04–2.27 | 4490 | 600–32,890 | |
40–49 | 1 | 0.13 | 0.02–1.14 | 2150 | 250–18,230 | |
50–59 | 2 | 0.74 | 0.16–3.41 | 11,240 | 2380–52,030 | |
60–69 | 1 | 0.44 | 0.06–3.34 | 5290 | 680–40,260 | |
70–79 | 0 | 0 | 0–4.51 | 0 | 0–36,840 | |
≥80 | 0 | 0 | 0–3.66 | 0 | 0–21,490 | |
All | 6 | 0.22 | 0.09–0.54 | 24,420 | 9990–59,940 | |